Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation

Shanna A. Arnold, Lee B. Rivera, Juliet G. Carbon, Jason E. Toombs, Chi Lun Chang, Amy D. Bradshaw, Rolf A. Brekken

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Fingerprint Dive into the research topics of 'Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation'. Together they form a unique fingerprint.

Chemical Compounds

Agriculture & Biology

Medicine & Life Sciences